Skip to content

The mobile health technology-based randomized controlled field intervention trial for the high-risk population of atherosclerotic cardiovascular disease: The ASCVD Risk Intervention Trial

The mobile health technology-based randomized controlled field intervention trial for the high-risk population of atherosclerotic cardiovascular disease

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042353
Enrollment
Unknown
Registered
2021-01-20
Start date
2020-09-01
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerotic cardiovascular disease

Interventions

Intensive intervention group:Mobile health device based interventions
General intervention group:Regular health talk interventions
The control group:Basic public health services

Sponsors

Shenzhen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) People with local household registration or resident time >= 6 months, who are not expected to leave their current residence in the next 3 years. 2) Aged 50-70 years. 3) Primary school or above and have the ability to read and write proficiently. 4) Included in the public heath management system of the community health service center or local health center. 5) Own and use a smart phone (able to use WeChat). 6) Participate in the study voluntarily and sign the informed consent. 7) CHINA-PAR was assessed as ASCVD high-risk population and intermediate risk population with high scores.

Exclusion criteria

Exclusion criteria: 1) Diagnosed with cardiovascular diseases, including stroke, coronary heart disease or myocardial infarction, or severe cardiac insufficiency (NYHA grade III or IV). 2) Having various malignant tumors. 3) Having mental disorders or alcoholism, have no self-control and cannot express themselves accurately;Inability to cooperate (cognitive impairment, physical and other obvious disorders). 4) Definitely diagnosed COPD and cor pulmonale. 5) Having secondary hypertension, thyroid, hypothalamic pituitary gland, adrenal gland and other endocrine diseases. 6) Having diseases requiring urgent treatment: such as acute infection, hypertensive crisis, diabetes mellitus complicated with ketoacidosis, etc. 7) Having severe abnormal liver and kidney function, autoimmune disease, or any serious and fatal disease. 8) Diagnosed with arteriosclerosis obliterans. 10) Having limitation of physical activity due to various causes. 11) Having Parkinson's disease, serious nervous system disease. 12) Having participated in its cardiovascular disease intervention trial.

Design outcomes

Primary

MeasureTime frame
10 - year risk score for atherosclerotic cardiovascular disease;ASCVD-related cardiovascular events;

Countries

China

Contacts

Public ContactDongsheng Hu

School of Public Health, Shenzhen University Health Science Center

hud@szu.edu.cn+86 755-86671951

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026